KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Gains from Sales and Divestitures (2020 - 2022)

GoodRx Holdings' Gains from Sales and Divestitures history spans 3 years, with the latest figure at $2.7 million for Q4 2022.

  • On a quarterly basis, Gains from Sales and Divestitures rose 466.81% to $2.7 million in Q4 2022 year-over-year; TTM through Dec 2022 was $2.7 million, a 466.81% increase, with the full-year FY2022 number at $2.7 million, up 466.81% from a year prior.
  • Gains from Sales and Divestitures hit $2.7 million in Q4 2022 for GoodRx Holdings, up from $743000.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for GDRX hit a ceiling of $16.4 million in Q4 2020 and a floor of $95000.0 in Q1 2021.
  • Historically, Gains from Sales and Divestitures has averaged $2.7 million across 3 years, with a median of $513000.0 in 2021.
  • Biggest five-year swings in Gains from Sales and Divestitures: tumbled 97.14% in 2021 and later soared 466.81% in 2022.
  • Tracing GDRX's Gains from Sales and Divestitures over 3 years: stood at $16.4 million in 2020, then tumbled by 97.14% to $470000.0 in 2021, then soared by 466.81% to $2.7 million in 2022.
  • Business Quant data shows Gains from Sales and Divestitures for GDRX at $2.7 million in Q4 2022, $743000.0 in Q3 2022, and $470000.0 in Q2 2022.